Pregene

Shenzhen Puruijin Biopharmaceutical Co., Ltd. operates as an investment entity for the National Small and Medium-sized Enterprise Development Fund and the Guokejiahe Fund affiliated with the Chinese Academy of Sciences. It holds distinctions as a national high-tech enterprise, a high-tech enterprise in Zhongguancun, and a high-tech enterprise in Shenzhen. Currently, it possesses the world's sole biopharmaceutical research and development platform integrating cell drugs and nanobody drugs.